Variational AI, developer of the Enki™ generative artificial intelligence (AI) drug discovery platform to redefine the economics of drug development, today announced that the company has filed two provisional patents… Read More about Variational AI Files Two US Provisional Patents for Potential COVID-19 Drug Created by Generative AI

Variational AI, developer of generative AI-based drug discovery platform for novel kinase inhibitors, today announced that it has added industry and scientific leader Jennifer Hamilton, Ph.D. as a company advisor. Read More about Variational AI Adds Jennifer Hamilton as Advisor

Variational AI, developer of generative AI-based drug discovery platform for novel kinase inhibitors, today announced that it has added industry and scientific leaders Dr. John F. Boylan and Dr. Mads… Read More about Variational AI Adds Leading Oncology Researchers to Scientific Advisory Board